cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Royalty Pharma Plc
10 own
19 watching
Current Price
$27.27
$-0.61
(-2.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
16,338.93M
52-Week High
52-Week High
34.65000
52-Week Low
52-Week Low
25.92000
Average Volume
Average Volume
1.89M
Dividend Yield
Dividend Yield
0.020496
P/E Ratio
P/E Ratio
24.6959
iconMarket Capitalization16,338.93M
icon52-Week High34.65000
icon52-Week Low25.92000
iconAverage Volume1.89M
iconDividend Yield0.020496
iconP/E Ratio24.6959
What does the Royalty Pharma Plc do?
N/A
Read More
How much money does Royalty Pharma Plc make?
News & Events about Royalty Pharma Plc.
Globe Newswire
1 year ago
NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2023 financial results on Tuesday, May 9, 2023 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. ...
Globe Newswire
1 year ago
Royalty Pharmas founder and Chief Executive Officer, Pablo Legorreta, has also indicated that he intends to purchase up to an additional $50 million of the companys Class A ordinary shares NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that the ...
Business Wire
1 year ago
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, and Royalty Pharma (Nasdaq: RPRX), the largest buyer of biopharmaceutical royalties and a...
Globe Newswire
1 year ago
Royalty Pharma now expects 2023 Adjusted Cash Receipts(1) (non-GAAP) to be between $2,850 million and $2,950 million, excluding contributions from future transactions NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has received a $475 million ...
Globe Newswire
1 year ago
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Ashwin Pai, M.D. as Executive Vice President, Investments. Ashwin will join Royalty Pharma in April 2023, and will report to Chris Hite, Executive Vice President and Vice Chairman. ...
Frequently Asked Questions
Frequently Asked Questions
What is Royalty Pharma Plc share price today?
plus_minus_icon
Can Indians buy Royalty Pharma Plc shares?
plus_minus_icon
How can I buy Royalty Pharma Plc shares from India?
plus_minus_icon
Can Fractional shares of Royalty Pharma Plc be purchased?
plus_minus_icon
What are the documents required to start investing in Royalty Pharma Plc stocks?
plus_minus_icon
What is today’s traded volume of Royalty Pharma Plc?
plus_minus_icon
What is today’s market capitalisation of Royalty Pharma Plc?
plus_minus_icon
What is the 52-Week High and Low Range of Royalty Pharma Plc?
plus_minus_icon
What percentage is Royalty Pharma Plc down from its 52-Week High?
plus_minus_icon
What percentage is Royalty Pharma Plc up from its 52-Week Low?
plus_minus_icon
Current Price
$27.27
$-0.61
(-2.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00